Developing treatments for rhodopsin-related dominant retinitis pigmentosa
<p>Mutations in the rhodopsin gene are one of the most common causes of autosomal dominant retinitis pigmentosa (ADRP) and there is at present no treatment available. In this thesis, three potential treatments were developed and tested in a R<em>ho</em><sup>P23H/+</sup>...
Auteur principal: | Orlans, H |
---|---|
Autres auteurs: | MacLaren, R |
Format: | Thèse |
Langue: | English |
Publié: |
2019
|
Sujets: |
Documents similaires
-
Nonretinoid chaperones improve rhodopsin homeostasis in a mouse model of retinitis pigmentosa
par: Abhishek Vats, et autres
Publié: (2022-05-01) -
TBC1D32 variants disrupt retinal ciliogenesis and cause retinitis pigmentosa
par: Béatrice Bocquet, et autres
Publié: (2023-11-01) -
Nrf2 overexpression rescues the RPE in mouse models of retinitis pigmentosa
par: David M. Wu, et autres
Publié: (2021-01-01) -
Adeno-associated virus mediated rhodopsin delivery in preventing secondary cone degeneration in rhodopsin knockout mice
par: Dauletbekov, D
Publié: (2016) -
Aggregation of rhodopsin mutants in mouse models of autosomal dominant retinitis pigmentosa
par: Sreelakshmi Vasudevan, et autres
Publié: (2024-02-01)